[Therapeutic update in gastroenterology].
During the last decade, advances in molecular biology and biotechnology allowed, the development of biological treatments aimed at more precise targets. New algorithms in inflammatory bowel diseases, chronic hepatitis C and digestive oncology are examples of the marked progress achieved by these therapies.
Belaiche
J
J
Service d'Hépato-Gastroentérologie, CHU Sart Tilman, ULg, Liège. Jacques.Belaiche@chu.ulg.ac.be
Delwaide
J
J
Polus
M
M
Louis
E
E
D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D007372:Interferons / Q000627:therapeutic use; D008113:Liver Neoplasms / Q000188:drug therapy*; D012254:Ribavirin / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D014409:Tumor Necrosis Factor-alpha; D012254:Ribavirin; D007372:Interferons